Patents
Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621)
08/2008
08/14/2008US20080194633 E.g., [(1-(2-aminoacetyl)-4-{N-[(3-fluoro-2-methylphenyl)methyl]carbamoyl}(4-piperidyl))methoxy]-N-(4-ethylphenyl)carboxamide; smooth muscle myosin or non-muscle myosin modulator; hypotensive agent; asthma, COPD, bronchoconstrictive disease, glaucoma, pre-menstrual cramps, erectile dysfunction
08/14/2008US20080194551 Acetylene Derivatives
08/14/2008CA2677387A1 Nitric oxide donor compounds
08/14/2008CA2677241A1 Compounds that inhibit cholinesterase
08/13/2008CN101239934A Technique for producing rivastigmine hydrogen tartrate
08/13/2008CN101239933A Low molecular weight organic gel and preparation method thereof
08/12/2008US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
08/12/2008US7410956 Caspase inhibitor prodrugs
08/12/2008CA2359819C 2-oxy-benzoxazinone derivatives for the treatment of obesity
08/07/2008US20080188654 Compounds for treatment of inflammation, diabetes and related disorders
08/07/2008US20080188561 N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
08/07/2008US20080188489 Cell differentiation inducer
08/07/2008US20080188468 Substituted Para-Trifluoromethyl Phenylate Compounds And Its Preparation And Use Thereof
08/07/2008US20080188371 use as pesticides and/or herbicides and/or microbicides; for the selective control of weeds; synergistic; low application rates and concentrations; in particular in cereals (especially wheat)
08/07/2008DE102007005720A1 Epoxid-Amin-Addukte als Dispergier- und Netzmittel Epoxy-amine adducts as dispersing and wetting agents
08/07/2008CA2676820A1 Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules
08/06/2008EP1951719A2 Certain chemical entities, compositions, and methods
08/06/2008EP1951671A2 New pleuromutilin derivative and its use
08/06/2008EP1951053A2 Cetp inhibitors
08/06/2008EP1397382B1 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
08/06/2008EP1311475B1 Aminocyclohexane derivatives
08/06/2008CN100408557C Method for preparing 2,4-toluene diamino menthyl formate
08/06/2008CN100408556C Modulation of anxiety through blockade of anandamide hydrolysis
08/05/2008US7408008 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support
08/05/2008CA2337098C Anthranilic acid derivatives
08/05/2008CA2222421C C-2' hydroxyl-benzyl protected, n-carbamate protected (2r,3s)-3-phenylisoserine and production process therefor
07/2008
07/31/2008WO2008042896A3 Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
07/31/2008US20080183003 Neuroprotective agents; nitrate-functional, for example 1-amino-3,5-dimethyl-7-nitrateadamantane hydrochloride
07/30/2008EP1948592A1 Organic compounds
07/30/2008CN101230020A Method for synthesizing macromonomer for polymer polyol by plant oil and uses thereof
07/30/2008CN101230008A Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
07/30/2008CN100406007C Asthma and allergic inflammation modulators
07/29/2008CA2348742C Carbocyclic potassium channel inhibitors
07/29/2008CA2275371C Phenylethylamine derivatives
07/29/2008CA2261835C Long-acting drugs and pharmaceutical compositions comprising them
07/29/2008CA2214323C Compounds and compositions for delivering active agents
07/24/2008WO2008033328A3 Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders
07/24/2008US20080177035 making side group protected homocysteine by reacting methionine with sodium in ammonia then alkylating the mercapto group such as with tert-butoxycarbonylalkyl protecting group; use as intermediate in synthesis cyclic peptides, particularly oxytocin antagonist peptides
07/24/2008US20080176939 Compounds which inhibit beta-secretase activity and methods of use thereof
07/24/2008US20080176821 phosphoryl-di(glutamate dibenzylester or dihydroxyamide) derivatives; neuroleptic agent, neurodegenerative diseases, neuropathic pain, epilepsy, ischaemia, schizophrenia, amyotrophic lateral sclerosis, Alzheimer's, Parkinson, Huntington diseases;
07/24/2008US20080176338 Derivatives of diethylenetriaminepentaacetic acid such as penta-tert-butyl 2-{4'-{2-[4-carboxy-4-fluorenyl methyloxycarbonylamino)]butyrylamido}benzyl}diethylenetriamine-pentakis(acetate); solid phase synthesis
07/23/2008CN101228116A Benzoyl-substituted serineamides
07/22/2008US7402600 Nitroderivatives of cardiovascular agents
07/22/2008CA2388076C Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
07/22/2008CA2343346C Process for the preparation of 4,5-diamino shikimic acid derivatives
07/22/2008CA2313638C Cyclohexene carboxylates as neuraminidase inhibitors
07/17/2008WO2008084086A1 Method for the production of o-vinylcarbamates and vinylcarbonates
07/17/2008WO2008083967A2 Process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acid
07/17/2008US20080171692 Substituted amides
07/17/2008CA2674291A1 New process
07/16/2008EP1942899A2 Mitotic kinesin inhibitors
07/16/2008EP1392655B1 Potassium channel openers
07/16/2008EP1381597B1 Process for preparing hydroxyethylamines
07/16/2008EP1244610B1 Improved preparation of 2s,3s-n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines
07/16/2008CN101219970A Method for synthesizing N-fluorene methoxycarbonyl-N-trityl-D-glutamine
07/16/2008CN100402495C Aminoalkylamide substituted cyclohexyl derivatives
07/10/2008WO2008082881A1 (meth)acryloyl-containing materials, compositions, and methods
07/10/2008WO2008081041A2 Amorphous and crystalline forms of rivastigmine hydrogentartrate
07/10/2008US20080167491 Simple and efficient preparation of an amino acid; used to prepare peptide nucleic acids (PNA) including those having photosensitive functional groups; reduction step of benzyloxycarbonyl- omega -amino acid derivatives
07/10/2008US20080167489 Transesterification of a hydroxyalkyl carbamate with an alkyl (meth)acrylate in the presence of an organotitanate, an organozirconate or an organotin catalyst; preparation of the carbamate by reacting an amine with a cyclic carbonate; sterically hindered phenolic polymerization inhibitor
07/10/2008US20080167310 Syndrome X, antidiabetic agents; hypoglycemic agents;antilipemic agents; artherosclerosis; cardiovascular disorders
07/09/2008EP1942100A1 Amorphous and crystalline forms of rivastigmine hydrogentartrate
07/09/2008EP1940783A1 Process for preparing n, n-substituted carbamoyl halides
07/09/2008EP1594853B1 Method for the production of bicyclic aromatic amino acids and intermediate products thereof
07/09/2008EP1465863B1 Potassium channel modulators
07/09/2008CN100400487C Glucocorticoid receptor modulators
07/08/2008CA2582172C Preparation of arthropodicidal oxadiazines
07/03/2008US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome
07/03/2008US20080161301 2-Oxy-Benzoxazinone Derivatives for the Treatment of Obesity
07/02/2008EP1939172A2 Method of obtaining phenyl carbamates
07/02/2008EP1496838A4 Substituted amides
07/02/2008CN101213199A Compounds for preparing immunological adjuvant
06/2008
06/26/2008US20080153899 Fatty amine drug conjugates
06/25/2008EP1934171A1 Methods for preparing glutamic acid derivatives
06/25/2008CN101205187A Substituted aryl ethers compounds as well as preparation and uses thereof
06/25/2008CN100396682C Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
06/19/2008US20080146778 Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same
06/19/2008US20080146661 Substituted arylamino -1,2,3,4-tetrahydro naphthalenes and -2,3-dihydro-1H-indenes as potassium channel modulators
06/19/2008US20080146647 Acetylene derivatives having mglur 5 antagonistic activity
06/19/2008US20080146632 Fc Receptor Modulating Compounds and Compositions
06/19/2008US20080146526 e.g. 3-{[1-Isobutanoyloxyethoxy]carbonylamino}propyl(n-butyl)phosphinic acid; prodrugs of baclofen; gamma aminobutanoic acid antagonist; antidepressant, anxiolytic agent, cognition activator; Alzheimer's disease, epilepsy
06/18/2008CN101200620A Curable hybrid electron donor compounds containing vinyl ether
06/17/2008US7388104 Fluorinated urethane compounds and compositions containing the same
06/17/2008CA2286772C Fungicide active substance combinations
06/17/2008CA2284468C Anti-inflammatory compounds
06/17/2008CA2163361C Therapeutic substituted guanidines
06/12/2008WO2008045391A3 Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate
06/12/2008US20080139630 Tissue-selective androgen receptor modulators (SARMs); male hypogonadism, prostate cancer, benign prostate hyperplasia, sarcopenia, rheumatoid arthritis and osteoarthritis; N-((5-cyclopropyl-2-fluoropyridin-3-yl)methyl)-2-phenylbutanamide for example
06/12/2008US20080139547 N-Hydroxyalkynylbenzamide (or hydroxamate) derivatives; anticarcinogenic and antiproliferative agents
06/12/2008US20080138817 Novel Functional Peptide Nucleic Acid Monomer and Process for Producing the Same
06/11/2008EP1930325A1 Process for producing optically active piperazine compound
06/11/2008EP1930021A2 Novel amide derivatives as growth hormone secretagogues
06/11/2008CN101195591A Method for producing hexa-methylene diamino-methyl formate with catalysis
06/10/2008US7385076 Process for the preparation of phenylcarbamates
06/10/2008US7384980 Derivatives of 3,3-diphenylpropylamines
06/10/2008US7384979 Substituted amino acids as erythropoietin mimetics
06/05/2008WO2008066900A1 1,4 diamino bicyclic retigabine analogues as potassium channel modulators
06/05/2008US20080131368 Technetium-base radiopharmaceuticals; biocompatability; kits
06/05/2008CA2670966A1 1,4 diamino bicyclic retigabine analogues as potassium channel modulators
06/04/2008EP1927584A1 Carrier for separation, method for separation of compound, and method for synthesis of peptide using the carrier
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 157